Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 18, 2022

View Archived Issues

Novel cdkl5-mutated zebrafish model of CDKL5 deficiency disorder

Insulin is tissue-specific, with link to weight complex

Purdue Research Foundation patents protein kinase inhibitors

Universite de Franche-Comte presents compounds targeting histamine H3 receptors

TCR-modified T cells targeting TdT show antileukemia promise in vivo

SCN5A tied to drug-induced cardiac arrythmia

PEGylated circularly permuted capsule depolymerase enzyme protects mice from anthrax infection

VelociT mouse model for analyzing T-cell function in human disease

Ono and Neurimmune expand drug discovery collaboration for neurodegenerative diseases

EZH2 as a promising therapeutic target for prostate cancer

MCC-1381, a pan-HDAC inhibitor with promising anticancer activity

ZIP8 found to correlate with severe rheumatoid arthritis

4basebio and eTheRNA collaborate to evaluate linear DNA for mRNA production

Avacta selects FAP-targeted proteasome inhibitor for preclinical development

SUW-133 diminishes HIV viral load in vivo

Researchers suggest ZEB2 targeting as an approach for atherosclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...